Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Olli Kurkela, Jorma Lahtela, Martti Arffman & Leena Forma. (2023) Infrared Thermography Compared to Standard Care in the Prevention and Care of Diabetic Foot: A Cost Analysis Utilizing Real-World Data and an Expert Panel. ClinicoEconomics and Outcomes Research 15, pages 111-123.
Read now
Read now
Benjamin Kearns, Katy Cooper, Anna Cantrell & Chloe Thomas. (2021) Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain. Neuropsychiatric Disease and Treatment 17, pages 125-137.
Read now
Read now
Qingwei Lu, Jun Wang, Xiaolu Wei, Gang Wang, Yang Xu, Zengzhen Lu & Peng Liu. (2020) Cost of Diabetic Foot Ulcer Management in China: A 7-Year Single-Center Retrospective Review. Diabetes, Metabolic Syndrome and Obesity 13, pages 4249-4260.
Read now
Read now
Heather Batten, Suzanne Kuys, Steven McPhail, Paulose Varghese & Allison Mandrusiak. (2019) Are people with lower limb amputation changing? A seven-year analysis of patient characteristics at admission to inpatient rehabilitation and at discharge. Disability and Rehabilitation 41:26, pages 3203-3209.
Read now
Read now
Massimiliano Povero, Antonio Miceli, Lorenzo Pradelli, Matteo Ferrarini, Matteo Pinciroli & Mattia Glauber. (2018) Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk. ClinicoEconomics and Outcomes Research 10, pages 733-745.
Read now
Read now
Raquel Sanchez-Santos, Esther Mariño Padin, Daniel Adam, Oleg Borisenko, Sergio Estevez Fernandez, Ester Carrera Dacosta, Sonia González Fernández, Juan Turnes Vazquez, Juan Carlos Ruiz de Adana & Felipe de la Cruz Vigo. (2018) Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 305-314.
Read now
Read now
Tatiana Dilla, Dimitra Alexiou, Ismini Chatzitheofilou, Ruba Ayyub, Julia Lowin & Kirsi Norrbacka. (2017) The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2. Journal of Medical Economics 20:5, pages 443-452.
Read now
Read now
K Chevreul, K Berg Brigham, C Gandré, L Mouthon & and the BURQOL-RD Research Network*. (2015) The economic burden and health-related quality of life associated with systemic sclerosis in France. Scandinavian Journal of Rheumatology 44:3, pages 238-246.
Read now
Read now
Hye-Eun JOO, Hyo-Jung LEE, Eun Jung SOHN, Min-Ho LEE, Hyun-Suk KO, Soo-Jin JEONG, Hyo-Jeong LEE & Sung-Hoon KIM. (2013) Anti-Diabetic Potential of the Essential Oil of Pinus koraiensis Leaves toward Streptozotocin-Treated Mice and HIT-T15 Pancreatic β Cells. Bioscience, Biotechnology, and Biochemistry 77:10, pages 1997-2001.
Read now
Read now
Katherine Esposito & Dario Giugliano. (2012) Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes. Expert Opinion on Biological Therapy 12:2, pages 209-221.
Read now
Read now
Carlo B Giorda, Valeria Manicardi & Jesús Diago Cabezudo. (2011) The impact of diabetes mellitus on healthcare costs in Italy. Expert Review of Pharmacoeconomics & Outcomes Research 11:6, pages 709-719.
Read now
Read now
Anne-Laure Guillermin, Yevgeniy Samyshkin, Donna Wright, Tini Nguyen & Julie Villeneuve. (2011) Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis. Journal of Medical Economics 14:2, pages 207-216.
Read now
Read now
Sandra L. Tunis, William D. Willis & Volker Foos. (2010) Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain. Current Medical Research and Opinion 26:1, pages 163-175.
Read now
Read now
Sandra L. Tunis, Michael E. Minshall, Christopher Conner, John I. McCormick, Jovana Kapor, Jean-François Yale & Danielle Groleau. (2009) Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis. Current Medical Research and Opinion 25:5, pages 1273-1284.
Read now
Read now
Manuela Helena Gschwend, Mark Aagren & William J Valentine. (2009) Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries. Journal of Medical Economics 12:2, pages 114-123.
Read now
Read now
D. Gregori, E. Pagano, R. Rosato, S. Bo, G. Zigon & F. Merletti. (2006) Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter?. Current Medical Research and Opinion 22:10, pages 1965-1971.
Read now
Read now
Stéphane Roze, William J. Valentine, Thomas Evers & Andrew J. Palmer. (2006) Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting. Current Medical Research and Opinion 22:7, pages 1415-1424.
Read now
Read now
Articles from other publishers (77)
Johan Jendle, Maria Ida BuompensiereAsli Zeynep Ozdemir SaltikSimona de PortuJayne Smith-Palmer, Richard F. PollockOhad Cohen. (2023) A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes. Diabetes Technology & Therapeutics 25:12, pages 864-876.
Crossref
Crossref
Anna L. Worsley, Dennis H. Lui, Winnie Ntow‐Boahene, Wenhui Song, Liam Good & Janice Tsui. (2022) The importance of inflammation control for the treatment of chronic diabetic wounds. International Wound Journal 20:6, pages 2346-2359.
Crossref
Crossref
Asaph Rolnitsky, Sharon Unger, David Urbach & Chaim M. Bell. (2023) The price of neonatal intensive care outcomes – in-hospital costs of morbidities related to preterm birth. Frontiers in Pediatrics 11.
Crossref
Crossref
Olli Kurkela, Jaakko Nevalainen, Martti Arffman, Jorma Lahtela & Leena Forma. (2022) Foot-related diabetes complications: care pathways, patient profiles and costs. BMC Health Services Research 22:1.
Crossref
Crossref
Yu Wang, Ping Zhang, Hui Shao, Linda J. Andes & Giuseppina Imperatore. (2022) Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes. Diabetes Care.
Crossref
Crossref
Ngan T. T. Dinh, Barbara de Graaff, Julie A. Campbell, Matthew D. Jose, Burgess John, Timothy Saunder, Alex Kitsos, Nadine Wiggins & Andrew J. Palmer. (2022) Costs of major complications in people with and without diabetes in Tasmania, Australia. Australian Health Review 46:6, pages 667-678.
Crossref
Crossref
Yu Wang, Ping Zhang, Hui Shao, Linda J. Andes & Giuseppina Imperatore. (2022) Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 2 Diabetes. Diabetes Care 45:11, pages 2570-2576.
Crossref
Crossref
Mi Jun Keng, Jose Leal, Louise Bowman, Jane Armitage & Borislava Mihaylova. (2022)
Hospital costs associated with adverse events in people with diabetes in the
UK
. Diabetes, Obesity and Metabolism 24:11, pages 2108-2117.
Crossref
Crossref
Sara Stafford, Peter G. Bech, Adam Fridhammar, Nino Miresashvili, Andreas Nilsson, Michael Willis & Aiden Liu. (2022) Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting. Applied Health Economics and Health Policy 20:4, pages 543-555.
Crossref
Crossref
Raija Lithovius, Anni A. Antikainen, Stefan Mutter, Erkka Valo, Carol Forsblom, Valma Harjutsalo, Niina Sandholm & Per-Henrik Groop. (2022) Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes. Diabetes Care 45:3, pages 734-741.
Crossref
Crossref
Isaac John Umaru, Maryam Usman Ahme, Bilyaminu Habibu, Imaranezor Kenneth, Philip Shadrach & Muhammad Zuhairah I. (2022) Protective Role of Solandra longiflora Flower Extracts on Streptozotocin Diabetes Induced Albino Rats. Asian Journal of Biochemistry 17:1, pages 7-14.
Crossref
Crossref
Diana G. Sami & Ahmed Abdellatif. 2021. Wound Healing Research. Wound Healing Research
431
458
.
J. Pöhlmann, K. Norrbacka, K. S. Boye, W. J. Valentine & H. Sapin. (2020) Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy. The European Journal of Health Economics 21:8, pages 1179-1196.
Crossref
Crossref
Muzammil H Syed, Konrad Salata, Mohamad A Hussain, Abdelrahman Zamzam, Charles de Mestral, Mark Wheatcroft, John Harlock, Deana Awartani, Badr Aljabri, Amol Verma, Fahad Razak, Subodh Verma & Mohammed Al-Omran. (2020) The economic burden of inpatient diabetic foot ulcers in Toronto, Canada. Vascular 28:5, pages 520-529.
Crossref
Crossref
Marco Ruggeri, Eleonora Bianchi, Silvia Rossi, Barbara Vigani, Maria Cristina Bonferoni, Carla Caramella, Giuseppina Sandri & Franca Ferrari. (2020) Nanotechnology-Based Medical Devices for the Treatment of Chronic Skin Lesions: From Research to the Clinic. Pharmaceutics 12:9, pages 815.
Crossref
Crossref
Hsuan-Ying Chen, Shihchen Kuo, Pei-Fang Su, Jin-Shang Wu & Huang-Tz Ou. (2020) Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up. Diabetes Care 43:8, pages 1732-1740.
Crossref
Crossref
Angela Shin-Yu Lien, Yi-Der Jiang, Jia-Ling Tsai, Jawl-Shan Hwang & Wei-Chao Lin. (2020) Prediction of Diabetic Nephropathy from the Relationship between Fatigue, Sleep and Quality of Life. Applied Sciences 10:9, pages 3282.
Crossref
Crossref
Carla Rognoni, Patrizio Armeni, Rosanna Tarricone & Gleb Donin. (2020) Cost–benefit Analysis in Health Care: The Case of Bariatric Surgery Compared With Diet. Clinical Therapeutics 42:1, pages 60-75.e7.
Crossref
Crossref
Jason K. Gurney, James Stanley, Steve York & Diana Sarfati. (2019) Regional variation in the risk of lower‐limb amputation among patients with diabetes in New Zealand. ANZ Journal of Surgery 89:7-8, pages 868-873.
Crossref
Crossref
Stephanie R. Johnson, Hannah E. Carter, Paul Leo, Samantha A. Hollingworth, Elizabeth A. Davis, Timothy W. Jones, Louise S. Conwell, Mark Harris, Matthew A. Brown, Nicholas Graves & Emma L. Duncan. (2019) Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 42:1, pages 69-76.
Crossref
Crossref
Jonathan Emeka Emordi, Esther Oluwatoyin Agbaje, Ibrahim Adekunle Oreagba & Osede Ignis Iribhogbe. (2018)
Antidiabetic Effects of the Ethanolic Root Extract of
Uvaria chamae
P. Beauv (Annonaceae) in Alloxan-Induced Diabetic Rats: A Potential Alternative Treatment for Diabetes Mellitus
. Advances in Pharmacological Sciences 2018, pages 1-13.
Crossref
Crossref
Barbara Bohn, Arthur Grünerbel, Marcus Altmeier, Carsten Giesche, Martin Pfeifer, Christian Wagner, Nikolai Heise, Frank Best, Peter Fasching & Reinhard W. Holl. (2018) Diabetic foot syndrome in patients with diabetes. A multicenter German/Austrian DPV analysis on 33 870 patients. Diabetes/Metabolism Research and Reviews 34:6, pages e3020.
Crossref
Crossref
Borja García-Lorenzo, Amado Rivero-Santana, Laura Vallejo-Torres, Iván Castilla-Rodríguez, Sonia García-Pérez, Lidia García-Pérez & Lilisbeth Perestelo-Pérez. (2018) Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain. Journal of Evaluation in Clinical Practice 24:4, pages 772-781.
Crossref
Crossref
Ignacio Conget, Pilar Martín-Vaquero, Stéphane Roze, Isabel Elías, Cristina Pineda, María Álvarez, Alexis Delbaere & Francisco Javier Ampudia-Blasco. (2018) Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Endocrinología, Diabetes y Nutrición 65:7, pages 380-386.
Crossref
Crossref
Ignacio Conget, Pilar Martín-Vaquero, Stéphane Roze, Isabel Elías, Cristina Pineda, María Álvarez, Alexis Delbaere & Francisco Javier Ampudia-Blasco. (2018) Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Endocrinología, Diabetes y Nutrición (English ed.) 65:7, pages 380-386.
Crossref
Crossref
Huidi Tchero, Pauline Kangambega, Lucien Lin, Martin Mukisi-Mukaza, Solenne Brunet-Houdard, Christine Briatte, Gerald Reparate Retali & Emmanuel Rusch. (2018) Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review. Annales d'Endocrinologie 79:2, pages 67-74.
Crossref
Crossref
Frank M. Davis, Andrew Kimball, Anna Boniakowski & Katherine Gallagher. (2018) Dysfunctional Wound Healing in Diabetic Foot Ulcers: New Crossroads. Current Diabetes Reports 18:1.
Crossref
Crossref
Raija Lithovius, Iiro Toppila, Valma Harjutsalo, Carol Forsblom, Per-Henrik Groop & Ville-Petteri Mäkinen. (2017) Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes. Diabetologia 60:7, pages 1234-1243.
Crossref
Crossref
Larisa Dmitrievna Popovich, Marina Vladimirovna Shestakova, Elena Georgievna Potapchik, Alexander Yur'evich Mayorov & Olga Konstantinovna Vikulova. (2017) Is it beneficial to the state to provide insulin-treated diabetic patients with public funds for self-monitoring blood glucose?. Diabetes mellitus 20:2, pages 108-118.
Crossref
Crossref
Michael P. Dillon, Lauren V. Fortington, Muhammad Akram, Bircan Erbas & Friedbert Kohler. (2017) Geographic Variation of the Incidence Rate of Lower Limb Amputation in Australia from 2007-12. PLOS ONE 12:1, pages e0170705.
Crossref
Crossref
Jose Ramón Caeiro, Agustí Bartra, Manuel Mesa-Ramos, Íñigo Etxebarría, Jorge Montejo, Pedro Carpintero, Francesc Sorio, Sonia Gatell, Andrea Farré & Laura Canals. (2016) Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study. Calcified Tissue International 100:1, pages 29-39.
Crossref
Crossref
J. E. Varney, D. Liew, T. J. Weiland, W. J. Inder & G. A. Jelinek. (2016) The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis. BMC Health Services Research 16:1.
Crossref
Crossref
Damian K Francis, Peter A Lazzarini, Trevor S Ferguson, Scott D Jen, Chisa Cumberbatch & Vivian Welch. (2016) Education of health professionals for preventing diabetic foot ulceration. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Shaurya Jhamb, Venkat N. Vangaveti & Usman H. Malabu. (2016) Genetic and molecular basis of diabetic foot ulcers: Clinical review. Journal of Tissue Viability 25:4, pages 229-236.
Crossref
Crossref
Laura Desveaux, Roger S. Goldstein, Sunita Mathur, Ali Hassan, Michael Devlin, Tim Pauley & Dina Brooks. (2016) Physical Activity in Adults with Diabetes Following Prosthetic Rehabilitation. Canadian Journal of Diabetes 40:4, pages 336-341.
Crossref
Crossref
James Cantley & Frances M. Ashcroft. (2015) Q&A: insulin secretion and type 2 diabetes: why do β-cells fail?. BMC Biology 13:1.
Crossref
Crossref
Robert B Hopkins, Natasha Burke, John Harlock, Jathishinie Jegathisawaran & Ron Goeree. (2015) Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Services Research 15:1.
Crossref
Crossref
Xiaoqian Liu, Yuanyuan Liu, Yuanjun Lv, Changping Li, Zhuang Cui & Jun Ma. (2015) Prevalence and temporal pattern of hospital readmissions for patients with type I and type II diabetes. BMJ Open 5:11, pages e007362.
Crossref
Crossref
Edouard Coeugniet, Marie-Pascale Tremblay-Champagne, Laurence Samuel Paek, Benoit Vanlerberghe, Daniel Suissa, Alain Michel Danino & Djafar Torabi. (2015) Effective Management of Diabetic Neuropathic Ulcers by Surgical Restoration of Foot Architecture: A Retrospective Study of 134 Cases. Canadian Journal of Diabetes 39:4, pages 278-284.
Crossref
Crossref
Peter A. Lazzarini, Sharon R. O’Rourke, Anthony W. Russell, Patrick H. Derhy & Maarten C. Kamp. (2015) Reduced Incidence of Foot-Related Hospitalisation and Amputation amongst Persons with Diabetes in Queensland, Australia. PLOS ONE 10:6, pages e0130609.
Crossref
Crossref
Kristien van Acker, Philippe Léger, Agnes Hartemann, Abhineet Chawla & Mohd Kashif Siddiqui. (2014) Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review. Diabetes/Metabolism Research and Reviews 30:8, pages 635-645.
Crossref
Crossref
Michael P Dillon, Friedbert Kohler & Victoria Peeva. (2014) Incidence of lower limb amputation in Australian hospitals from 2000 to 2010. Prosthetics & Orthotics International 38:2, pages 122-132.
Crossref
Crossref
Vanessa J Houghton, Virginia M Bower & David C Chant. (2013) Is an increase in skin temperature predictive of neuropathic foot ulceration in people with diabetes? A systematic review and meta-analysis. Journal of Foot and Ankle Research 6:1.
Crossref
Crossref
A. Sicras Mainar, C. Roldán Suárez, B. Font Ramos, R. Navarro Artieda & J. Ibáñez Nolla. (2013) Clinical and economical consequences of the combination of metformin with dipeptidyl peptidase inhibitors in type 2 diabetes patients. Revista Clínica Española (English Edition) 213:8, pages 377-384.
Crossref
Crossref
A. Sicras Mainar, C. Roldán Suárez, B. Font Ramos, R. Navarro Artieda & J. Ibáñez Nolla. (2013) Consecuencias clínicas y económicas de la combinación de metformina con inhibidores de la dipeptidilpeptidasa en pacientes con diabetes tipo 2. Revista Clínica Española 213:8, pages 377-384.
Crossref
Crossref
Tomaž Nerat & Mitja Kos. (2013) Burden of Type 2 Diabetes from the Healthcare Payer Perspective in Slovenia / Breme Sladkorne Bolezni Tipa 2 S Stališča Plačnika Zdravstvenega Varstva V Sloveniji. Slovenian Journal of Public Health 52:3, pages 162-180.
Crossref
Crossref
Falk Hoffmann, Heiner Claessen, Stephan Morbach, Regina Waldeyer, Gerd Glaeske & Andrea Icks. (2013) Impact of diabetes on costs before and after major lower extremity amputations in Germany. Journal of Diabetes and its Complications 27:5, pages 467-472.
Crossref
Crossref
Damian K Francis, Peter A Lazzarini, Trevor S Ferguson, Scott D Jen, Chisa Cumberbatch & Vivian Welch. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Peter A Lazzarini, Joel M Gurr, Joseph R Rogers, Andrew Schox & Shan M Bergin. (2012) Diabetes foot disease: the Cinderella of Australian diabetes management?. Journal of Foot and Ankle Research 5:1.
Crossref
Crossref
Peter A Lazzarini, Sharon R O’Rourke, Anthony W Russell, Damien Clark & Suzanne S Kuys. (2012) What are the key conditions associated with lower limb amputations in a major Australian teaching hospital?. Journal of Foot and Ankle Research 5:1.
Crossref
Crossref
D. Graillot, V. Quipourt, B. Bouillet, J.-M. Petit & P. Manckoundia. (2012) Diabète de type 2 chez le sujet âgé : quelles spécificités ?. La Revue de Médecine Interne 33:10, pages 575-579.
Crossref
Crossref
Antonio Ceriello, László Barkai, Jens Sandahl Christiansen, Leszek Czupryniak, Ramon Gomis, Kari Harno, Bernhard Kulzer, Johnny Ludvigsson, Zuzana Némethyová, David Owens, Oliver Schnell, Tsvetalina Tankova, Marja-Riitta Taskinen, Bruno Vergès, Raimund Weitgasser & Johan Wens. (2012) Diabetes as a case study of chronic disease management with a personalized approach: The role of a structured feedback loop. Diabetes Research and Clinical Practice 98:1, pages 5-10.
Crossref
Crossref
Dario Giugliano & Katherine Esposito. (2012) Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes. Therapeutic Advances in Endocrinology and Metabolism 3:3, pages 99-108.
Crossref
Crossref
Antonio Pérez Pérez, Ricardo Gómez Huelgas, Fernando Álvarez Guisasola, Javier García Alegría, José Javier Mediavilla Bravo & Edelmiro Menéndez Torre. (2012) Documento de consenso sobre el tratamiento al alta hospitalaria del paciente con hiperglucemia. Medicina Clínica 138:15, pages 666.e1-666.e10.
Crossref
Crossref
Walter P. Wodchis, R. Sacha Bhatia, Kori Leblanc, Nazanin Meshkat & Dante Morra. (2012) A Review of the Cost of Atrial Fibrillation. Value in Health 15:2, pages 240-248.
Crossref
Crossref
Monika Scheuringer, Narine Sahakyan, Karl J Krobot & Volker Ulrich. (2012) Cost of clinical events in health economic evaluations in Germany: a systematic review. Cost Effectiveness and Resource Allocation 10:1, pages 7.
Crossref
Crossref
Sandra L. Tunis. (2011) Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin. Applied Health Economics and Health Policy 9:6, pages 351-365.
Crossref
Crossref
Gordon Goodall, María Costi, Louise Timlin, Jesús Reviriego, José Antonio Sacristán, Jayne Smith-Palmer & Tatiana Dilla. (2011) Coste-efectividad de exenatida en comparación con insulina glargina en pacientes con obesidad y diabetes mellitus tipo 2 en España. Endocrinología y Nutrición 58:7, pages 331-340.
Crossref
Crossref
Gordon Goodall, María Costi, Louise Timlin, Jesús Reviriego, José Antonio Sacristán, Jayne Smith-Palmer & Tatiana Dilla. (2011) Cost-effectiveness of exenatide versus insulin glargine in Spanish patients with obesity and type 2 diabetes mellitus. Endocrinología y Nutrición (English Edition) 58:7, pages 331-340.
Crossref
Crossref
P. Valensi & S. Picard. (2011) Lipids, lipid-lowering therapy and diabetes complications. Diabetes & Metabolism 37:1, pages 15-24.
Crossref
Crossref
Lenore MandersonNarelle Warren. (2010) The Art of (Re)Learning to Walk: Trust on the Rehabilitation Ward. Qualitative Health Research 20:10, pages 1418-1432.
Crossref
Crossref
T. Kristensen, M. Laudicella, C. Ejersted & A. Street. (2010) Cost variation in diabetes care delivered in English hospitals. Diabetic Medicine 27:8, pages 949-957.
Crossref
Crossref
Sandra L. Tunis, Luc Sauriol & Michael E. Minshall. (2010) Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada. Applied Health Economics and Health Policy 8:4, pages 267-280.
Crossref
Crossref
A. Icks, B. Haastert, A. Gandjour, N. Chernyak, W. Rathmann, G. Giani, L. C. Rump, R. Trapp & M. Koch. (2009) Costs of dialysis--a regional population-based analysis. Nephrology Dialysis Transplantation 25:5, pages 1647-1652.
Crossref
Crossref
Yang Zhao, Wenyu Ye, Kristina S. Boye, John H. Holcombe, Jerry A. Hall & Ralph Swindle. (2010) Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. Journal of Diabetes and its Complications 24:1, pages 9-19.
Crossref
Crossref
T. Mittendorf, J. Smith-Palmer, L. Timlin, M. Happich & G. Goodall. (2009) Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting. Diabetes, Obesity and Metabolism 11:11, pages 1068-1079.
Crossref
Crossref
Björn Schwander, Birgit Gradl, York Zöllner, Peter Lindgren, Hans-Christoph Diener, Stephan Lüders, Joachim Schrader, Fernando Antoñanzas Villar, Wolfgang Greiner & Bengt Jönsson. (2009) Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model. Value in Health 12:6, pages 857-871.
Crossref
Crossref
Cosimo Giannini, Angelika Mohn & Francesco Chiarelli. (2009) Technology and the issue of cost/benefit in diabetes. Diabetes/Metabolism Research and Reviews 25:S1, pages S34-S44.
Crossref
Crossref
Shabana Tharkar, Kumpatla Satyavani & Vijay Viswanathan. (2009) Cost of medical care among type 2 diabetic patients with a co-morbid condition—Hypertension in India. Diabetes Research and Clinical Practice 83:2, pages 263-267.
Crossref
Crossref
James L. Palmer, Meaghan Gibbs, Huib WKFH Scheijbeler, Robert W. Kotchie, Steffen Nielsen, Jeremy White & William J. Valentine. (2008) Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China. Advances in Therapy 25:8, pages 752-774.
Crossref
Crossref
J. Reviriego, R. Gomis, J. P. Marañés, W. Ricart, P. Hudson & J. A. Sacristán. (2008) Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia. International Journal of Clinical Practice 62:7, pages 1026-1032.
Crossref
Crossref
Philip Clarke, Jose Leal, Chris Kelman, Merran Smith & Stephen Colagiuri. (2008) Estimating the Cost of Complications of Diabetes in Australia Using Administrative Health-Care Data. Value in Health 11:2, pages 199-206.
Crossref
Crossref
Jolita Ciapaite, Stephan J. L. Bakker, Robert J. Heine, Klaas Krab & Hans V. Westerhoff. 2007. Molecular System Bioenergetics. Molecular System Bioenergetics
571
592
.
Tri VuongLouis C. MartineauCharles RamassamyChantal MatarPierre S. Haddad. (2007) Fermented Canadian lowbush blueberry juice stimulates glucose uptake and AMP-activated protein kinase in insulin-sensitive cultured muscle cells and adipocytesThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products.. Canadian Journal of Physiology and Pharmacology 85:9, pages 956-965.
Crossref
Crossref
Arthorn Riewpaiboon, Penkae Pornlertwadee & Kwanjai Pongsawat. (2007) Diabetes Cost Model of a Hospital in Thailand. Value in Health 10:4, pages 223-230.
Crossref
Crossref
David A. Savage, Stephen C. Bain, Amy Jayne McKnight & A. Peter Maxwell. (2007) Gene discovery in diabetic nephropathy. Current Diabetes Reports 7:2, pages 139-145.
Crossref
Crossref
Neale Cohen, Michael E Minshall, Lyn Sharon-Nash, Katerina Zakrzewska, William J Valentine & Andrew J Palmer. (2007) Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin. PharmacoEconomics 25:10, pages 881-897.
Crossref
Crossref